Bayer's supervisory board hire lawyer for glyphosate litigation
Reuters
Published Jun 26, 2019 17:59
Bayer's supervisory board hire lawyer for glyphosate litigation
FRANKFURT (Reuters) - German chemicals giant Bayer (DE:BAYGN) on Wednesday said its supervisory board will form a committee to address glyphosate litigation, retaining a lawyer to give a fresh perspective on how to resolve a multi-billion dollar legal problem.
Bayer said it has hired U.S. lawyer John H. Beisner to advise the Supervisory Board on matters related to the glyphosate litigations, including trial tactics and mediation, on an ongoing basis.
"His appointment is intended to add fresh and independent perspectives to the advice given to the Board of Management," the company said in a statement on Wednesday.
Bayer faces massive legal issues in the United States where more than 13,400 plaintiffs allege the company's Roundup weedkiller, produced by U.S. unit Monsanto (NYSE:MON), caused cancer and that the company failed to warn about that risk. Bayer denies this.
Bayer, which acquired Monsanto in a $63 billion deal last year, says studies and regulators have deemed glyphosate and Roundup safe for human use.
Bayer on Wednesday said a new Supervisory Board committee, comprised of eight supervisory board members, will consult with the Board of Management and make recommendations on litigation strategy.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.